Immunotherapy Talks with ACIR
Immunotherapy Talks with ACIR
Accelerating Cancer Immunotherapy Research (ACIR)
#2 - A biomaterial-based vaccine
23 minutes Posted Jun 2, 2022 at 4:00 pm.
Background about the study
GUEST: Alex Najibi
0:00
23:46
Download MP3
Show notes

In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells.
GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab.
Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/ 

Support the show

Thanks for listening! Let’s stay in touch: